Close Menu

NEW YORK (GenomeWeb) – Transgenomic said after the close of the market on Friday that its second quarter sales revenues rose slightly year over year.

For the three months ended June 30, the firm reported revenues of $505,000 compared to $442,000 in the year-ago quarter.

The company's laboratory services revenues were flat year over year, with the slight increase in total revenues due to oncology revenues and awarded grants.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.